Related by context. All words. (Click for frequent words.) 76 Lorianne Masuoka MD 72 Paolo Paoletti MD 72 Vojo Vukovic MD Ph.D. 71 Spiro Rombotis President 71 Steven A. Kriegsman 69 Michael H. Tardugno 69 Joshua Boger Ph.D. 69 Dan Passeri Curis 69 Nancy Simonian MD 68 Evoltra ® 68 oral picoplatin 68 Mohammad Azab MD 68 Daniel Junius 67 Howard H. Pien 67 kidney urologic 67 HuLuc# 67 Pedro Lichtinger 67 delay bone metastases 67 alvespimycin 67 Jeffrey H. Buchalter 66 ® bortezomib 66 Safi Bahcall Ph.D. 66 motesanib 66 thetreatment 66 dexanabinol 66 Keith Katkin 66 Dr. Wolfgang Wein 66 Allovectin 7 ® 66 Panzem R NCD 66 Neil K. Warma 66 MAGE A3 ASCI 66 Panzem 66 lumiliximab 66 Norbert Bischofberger PhD 66 Dr. Aiping Young 66 Lisa N. Drakeman 66 J. Donald deBethizy 66 Steven R. Deitcher 66 BrachySil TM 66 CYT# potent vascular disrupting 66 Rosen ViroPharma 66 Aplidin 66 sorafenib tablets 66 Sudhir Agrawal D.Phil 66 metaglidasen 65 SUTENT ® 65 Alessandro Riva 65 Dr. Marlies Sproll 65 Mark A. Sirgo 65 Dr. Arndt Schottelius 65 Exherin TM 65 forodesine 65 midstage clinical 65 Fibrillex TM 65 Loretta M. Itri 65 Dr. Raafat Fahim 65 Akshay Vaishnaw MD Ph.D. 65 Solazed 65 IMA# 65 tramiprosate Alzhemed TM 65 Onno van de Stolpe 65 novel immunotherapies 65 DCVax R 65 CEQ# 65 R sorafenib tablets 65 ospemifene 65 fusion enhancers 65 THR beta agonist 65 Georges Gemayel 65 cannabinor 65 Mark HN Corrigan 65 novel therapeutic antibodies 65 OHR/AVR# 64 CRD5 64 MGd 64 oral antiviral 64 Vandetanib 64 anti angiogenic agents 64 TOCOSOL Camptothecin 64 advanced carcinoid 64 Lixivaptan 64 nalbuphine ER 64 inhibit metastasis 64 cyclophosphamide chemotherapy 64 KIACTA ™ 64 Ph.D. Targacept 64 Asentar 64 Potelligent Technology 64 Virulizin ® 64 Archexin 64 Harry Palmin President 64 rindopepimut 64 Elacytarabine 64 MediGene focuses 64 Uli Hacksell Ph.D. 64 Dr. Fahar Merchant 64 Lonnie Moulder 64 Ron Bentsur 64 YONDELIS 64 Tykerb lapatinib 64 Allovectin 7 64 PSMA ADC 64 chronic thromboembolic pulmonary 64 lymphomas leukemias 64 HQK 64 Abiraterone acetate 64 Daniel Passeri Curis 64 CCR9 antagonist 64 commercialize deforolimus 64 refractory colorectal cancer 64 acetonide FA 64 ganetespib 64 optimal dosing regimens 64 samalizumab 64 Philip Mease 64 EndoTAGTM 1 64 Mr. Armando Anido 63 Darinaparsin 63 Kemal Malik 63 TroVax ® 63 Edward Lanphier Sangamo 63 ixabepilone 63 Trofex 63 lintuzumab SGN 63 CA4P 63 Liposomal Grb 2 63 Raymond P. Warrell 63 ELACYT 63 Carl A. Pelzel 63 NP2 Enkephalin 63 Antony Koblish President 63 lung pancreatic 63 deforolimus 63 sunitinib malate 63 Clay B. Siegall 63 rhIGF-I/rhIGFBP-3 63 Dr. Joseph Feczko 63 HCV protease inhibitors 63 HGS ETR1 mapatumumab 63 receptor tyrosine kinase inhibitor 63 ASONEP 63 demonstrated antitumor activity 63 BZL# 63 AQ4N 63 multiple myeloma MM 63 IMiDs 63 Sol J. Barer 63 tanespimycin 63 GVAX ® 63 TELINTRA 63 Vidaza azacitidine 63 oral prodrug 63 oxypurinol 63 axitinib 63 Phase #b/#a clinical 63 relapsed MM 63 Dr. Wayne Danter 63 Cloretazine 63 CytoFab 63 TNF blocker therapy 63 TTF Therapy 63 Thalomid ® 63 osteolytic bone disease 63 Egrifta 63 novel VDA molecule 63 triphendiol 63 metastatic colorectal 63 talactoferrin 63 drug Treanda 63 HGS ETR2 63 dacetuzumab 63 sunitinib Sutent 63 MyVax personalized immunotherapy 63 CMV vaccine 63 Iris Loew Friedrich 63 Omacetaxine 63 Canvaxin 63 Symadex 63 IAP inhibitor 63 Bezielle 63 Eliezer Zomer Ph.D. 63 Jack Lief Arena 63 PEG PAL 63 Elliott Sigal MD Ph.D. 63 BRAF mutant 63 Jacob Inbar 63 Behcet uveitis 63 stated Michelle Berrey 63 Hoyoung Huh MD Ph.D. 63 Zemplar Capsules 63 HCD# [002] 63 Chemophase 63 therapeutic monoclonal antibody 63 Gleevec Glivec 62 immune modulating 62 riociguat 62 Jean Jacques Bienaime 62 PEG SN# 62 tubulin inhibitor 62 Mace Rothenberg 62 James Manuso 62 Nicholas Nicolaides 62 Barry D. Quart 62 dirucotide MBP# 62 taxane refractory 62 Hakan Edstrom 62 pediatric acute lymphoblastic 62 Folotyn 62 Roger Perlmutter Amgen 62 Jeffrey M. Ostrove 62 vidofludimus 62 hematological indications 62 Amgen Neulasta ® 62 pain palliation 62 BENLYSTA ® 62 Michael Fonstein Ph.D. 62 Velcade bortezomib 62 Allovectin 7 R 62 Aclidinium 62 Mipomersen 62 Dan Passeri 62 Arranon 62 glufosfamide 62 FUSILEV enhances 62 Cloretazine R 62 GVAX Pancreas Vaccine 62 HGS# 62 drug figitumumab 62 myeloproliferative neoplasms MPNs 62 GED aPC 62 Amgen Neulasta R 62 IMC #B 62 SNT MC# 62 OncoVex 62 paclitaxel Taxol ® 62 fibrotic disease 62 targeted radiotherapeutic 62 histone deacetylase inhibitor 62 Adelene Q. Perkins 62 Aviptadil 62 NV1FGF 62 eritoran 62 AAG geldanamycin analog 62 sargramostim 62 Campath ® 62 figitumumab 62 Zemiva TM 62 Dendreon investigational 62 dasatinib Sprycel 62 Jorge Cortes MD 62 Aflibercept 62 lenalidomide dexamethasone 62 cytotoxic therapies 62 either acutely decompensated 62 metastatic bladder 62 oral methylnaltrexone 62 OnDose TM 62 Troxatyl 62 refractory Hodgkin 62 MAXY VII 62 Biopharm Development 62 Somatuline Depot 62 XP# XP# 62 ularitide 62 Mr. Jinsheng Ren 62 David Aviezer 62 potent suppressor 62 Vitaxin 62 AEG# 62 PDE# inhibitors 62 Paul Laikind 62 Steve Cartt Executive 62 Onconase 62 HuCNS SC ® 62 hepatocellular carcinoma liver 62 gastro intestinal inflammation 62 cisplatin chemotherapy 62 metastatic carcinoid 62 gastrointestinal mucositis 62 Insegia 62 class mGluR5 inhibitor 62 psoriasis rheumatoid arthritis 62 Removab 62 oncolytic virus therapies 62 erlotinib Tarceva 62 Peginterferon alfa 2b 62 PROCHYMAL 62 EP #R 62 Annamycin 62 Urocidin 62 aflibercept VEGF Trap 62 Vicinium TM 62 EndoTAG TM -1 62 systemic RNAi 62 myelofibrosis polycythemia vera 62 JAK inhibitors 62 PRT# 62 enzastaurin 62 Kleanthis G. Xanthopoulos Ph.D. 62 #D#C# 62 Tarvacin Anti Cancer 62 Nexavar ® 62 Combivir Kivexa 62 sapacitabine CYC# 62 Phase #/#a trial 62 BioNumerik 62 novel anticancer 62 Donald L. Drakeman 62 amrubicin 62 incyclinide 62 MYLOTARG 62 obatoclax 62 neratinib 62 Jean Pierre Sommadossi Ph.D. 62 refractory acute myeloid 62 Yvonne Greenstreet 62 Personalized Immunotherapy 62 bladder ovarian 62 E2F Decoy 62 Bob Butchofsky President 62 polycythemia vera essential thrombocythemia 62 IL# PE#QQR 62 GRN# 62 Vascugel TM 61 Phase IIb clinical trials 61 Bayer HealthCare Onyx Pharmaceuticals 61 RhuDex R 61 isoform selective 61 Friedhelm Blobel Ph.D. 61 mTOR inhibition 61 investigational therapies 61 EVIZON TM 61 Tarceva TM 61 relapsed multiple myeloma 61 budesonide foam 61 anticancer therapeutics 61 Neulasta ® 61 PLX cells 61 CBLC# 61 PrevOnco ™ 61 MAXY G# 61 Perforomist ™ Inhalation Solution 61 mertansine 61 Aggrastat ® tirofiban hydrochloride 61 novel tubulin binding 61 Dacogen injection 61 skeletal metastases 61 endocrine therapies 61 Ceflatonin 61 Surfaxin LS 61 OvaRex R 61 Xanafide 61 AKT inhibitor 61 lucinactant 61 Teverelix 61 Dacogen decitabine 61 Alton Boynton 61 Orville G. Kolterman 61 investigational monoclonal antibody 61 Sanjay Bhanot 61 Pazopanib 61 corticosteroid dexamethasone 61 TTR amyloidosis 61 haematologic malignancies 61 MMP inhibitors 61 Vascugel 61 tafamidis 61 Peter A. Lankau 61 Davanat 61 darapladib 61 TRISENOX 61 DCVax ® 61 tremelimumab 61 PLK1 SNALP 61 Ribavirin causes 61 Azedra 61 BRAF inhibitor 61 omega interferon 61 ANAVEX #-# [001] 61 Onyx Pharmaceuticals Announces 61 Vidofludimus 61 Curaxin 61 ZOLINZA 61 Tavocept 61 MyVax ® 61 Trevor Mundel 61 triggers apoptosis programmed 61 AERx ® 61 pemphigus vulgaris 61 acyclovir Lauriad R 61 humanized therapeutic 61 docetaxel Taxotere ® 61 Proxinium TM 61 Marc Cluzel 61 Per Olof Wallström 61 relapsed refractory AML 61 PLX STROKE targeting 61 chemopreventive agent 61 Immunotherapeutic 61 Francois Nader 61 TYSABRI natalizumab 61 bavituximab monotherapy trial 61 elotuzumab 61 Brian JG Pereira 61 refractory chronic lymphocytic 61 AMPK activators 61 neovascular diseases 61 Michael V. Novinski 61 tosedostat 61 Dr. Karl Mettinger 61 LymphoStat B TM 61 esophageal candidiasis 61 otelixizumab 61 thalidomide Thalomid 61 hematological cancers 61 Phase 1b clinical trials 61 torsemide ER 61 accumulate preferentially 61 GRNOPC1 contains 61 OMP #M# 61 Panzem R 61 MCSP respectively 61 Albuferon albinterferon alfa 2b 61 evaluating tivozanib 61 chemosensitizer 61 docetaxel Taxotere R 61 personalized immunotherapy 61 mapatumumab 61 infectious diseases autoimmune diseases 61 K ras mutations 61 Remi Barbier 61 vosaroxin 61 Steve Worland Ph.D. 61 Dino Dina 61 huC# DM4 61 HepaMate ™ 61 PEG Interferon lambda 61 Hepatocellular Carcinoma HCC 61 Nexavar sorafenib 61 Pimavanserin 61 Xcytrin R 61 colorectal lung 61 brivaracetam 61 radiolabeled TM# 61 orBec 61 epigenetic therapies 61 relapsed leukemia 61 oral talactoferrin 61 Revlimid lenalidomide 61 Campath alemtuzumab 61 cMET 61 Hedgehog antagonist 61 ulimorelin 61 Pseudomonas aeruginosa infections 61 diabetic kidney 61 PNP inhibitor 61 Noxafil 61 Erbitux cetuximab 61 Oral NKTR 61 Exelixis compounds 61 INTEGRILIN R eptifibatide Injection 61 liposomal doxorubicin 61 Xelox 61 proteasome inhibitor 61 mitoxantrone plus 61 Daclizumab 61 Wellstat 61 hypereosinophilic syndrome 61 recurrent metastatic ovarian cancer 61 XL# SAR# 61 Mr. Yves Rosconi 61 panitumumab Vectibix 61 Budesonide foam crofelemer 61 immuno modulatory 61 potentially hepatotoxic 61 EndoTAG TM 61 lipid lowering therapies 61 Vertex hepatitis C 61 successfully commercialize Iluvien 61 Dr. Randall Yatscoff 61 ® natalizumab 61 Paolo Paoletti 61 Diamyd ® 61 HGS ETR1 61 IMiDs ® 61 paclitaxel poliglumex 61 IMiDs R 61 ProSavin 61 JAK inhibitor 61 Crofelemer budesonide foam 61 UPLYSO 61 blood clot dissolving 60 AE# vaccine 60 cediranib 60 atacicept 60 chronic idiopathic thrombocytopenic purpura 60 non hodgkin lymphoma 60 Syncria 60 LymphoStat B belimumab 60 Benlysta belimumab 60 adalimumab Humira 60 NeoLipid R 60 PI3K/Akt pathway inhibitor 60 velafermin 60 Triapine R 60 Phase #b/#a 60 Pruvel 60 sitaxsentan 60 hypoxia activated prodrug 60 antiresorptive 60 Cardio Vascu Grow 60 pancreatic lung 60 patients receiving myelosuppressive 60 gefitinib Iressa 60 ONCONASE R 60 MDS AML 60 progressive metastatic prostate 60 maximally tolerated 60 galiximab 60 ImmunoVEX HSV2 60 gemcitabine Gemzar ® 60 AFREZZA TM 60 MNTX 60 Tasigna prolongs 60 BAY #-# 60 Hal Barron 60 CDAD Clostridium difficile 60 metastatic renal cell 60 Generx TM 60 systemic ALCL 60 candidate TNFerade biologic 60 nucleotide analog 60 indolent NHL 60 systemically administered 60 CTAP# Capsules 60 Hedgehog inhibitor 60 reslizumab 60 CR# vcMMAE 60 TRIOLEX HE# APOPTONE HE# 60 #I TM# 60 vaso occlusive crisis 60 Arcalyst 60 Soliris TM eculizumab 60 cardio metabolic diseases 60 DACH platinum 60 p# inhibitor 60 preclinically 60 HER2 positive cancers 60 Elisabeth Lindner CEO 60 R vitespen 60 vismodegib 60 cirrhosis liver failure 60 treating neuropathic pain 60 Phenoptin 60 TG# [003] 60 mGluR2 NAM 60 lenalidomide Revlimid R 60 DXL# 60 TBC# 60 liver metastasis 60 deCODE ProstateCancer TM 60 lomitapide 60 ocrelizumab 60 haematological cancers 60 Jean Francois Rossignol 60 Gregory A. Demopulos 60 Trastuzumab DM1 60 Muraglitazar 60 Cx# [002] 60 Elliott Sigal 60 r hGH 60 Onrigin 60 gemcitabine chemotherapy 60 Litx 60 GALNS 60 Zami Aberman Chairman 60 IV Busulfex 60 Severe VOD 60 allogeneic HSCT 60 Liprotamase 60 FOLFOX chemotherapy 60 SonoLysis 60 PRESEPT study 60 Aloxi injection 60 Abbokinase 60 multitargeted 60 including eniluracil ADH 60 Andy Boorn 60 Trofex TM 60 ATL/TV# 60 CDP# 60 immune modulatory 60 Alzhemed TM 60 RSR# 60 selective modulator 60 vinflunine 60 catheter occlusion 60 TNF antagonist 60 Macular edema 60 H. Kirn 60 leukemia multiple myeloma 60 MetMAb 60 tramiprosate ALZHEMED TM 60 cardiometabolic disorders 60 volociximab 60 tumor vascular disrupting 60 Selzentry Celsentri 60 ruxolitinib 60 targeted antifolate 60 Ixempra 60 TRAIL receptor antibodies 60 leukemia myeloma 60 OncoVEX 60 refractory gout 60 steroid refractory GvHD 60 recombinant interferon 60 GTC recombinant human 60 proliferative disorders 60 unresectable tumors 60 R#/MEM # 60 MYDICAR ® 60 Prestara 60 leading oral taxane 60 OMP #R# 60 ATL# [002] 60 iroxanadine 60 EnVivo 60 relapsing remitting MS RRMS 60 heterozygous FH 60 Kathy Giusti Founder 60 Frank Verwiel MD 60 familial hypercholesterolemia FH 60 chemotherapeutic regimen 60 UVIDEM 60 sorafenib Nexavar 60 radiotherapeutic 60 SNT-MC#/idebenone 60 INSPIRE Trial Phase III 60 recurrent glioblastoma multiforme GBM 60 Vaxfectin TM 60 JAK2 inhibitor 60 recurrent glioblastoma 60 Anidulafungin 60 Sebivo 60 Tumour Vascular Disrupting Agent 60 oxymorphone ER 60 adecatumumab 60 Cytoxan 60 chemotherapy induced neutropenia 60 cobiprostone 60 Cimzia TM 60 Squalamine 60 standard chemotherapy regimen 60 Golimumab 60 multiple sclerosis psoriasis 60 Gleevec imatinib mesylate 60 radiation sensitizer 60 maribavir 60 talabostat 60 nonsmall cell lung cancer 60 BRAF inhibitors 60 imatinib Gleevec ® 60 immunological diseases 60 Adnectin 60 MabThera Rituxan 60 eniluracil 60 Pascal Pfister 60 oral deforolimus 60 relapsed ALL 60 liposomal formulation 60 CA9 SCAN 60 SomatoKine 60 Sutent sunitinib 60 hereditary deficiency 60 DAVANAT 60 gastrointestinal stromal 60 Gleevec resistant 60 trastuzumab DM1 T DM1 60 ALK inhibitors 60 MyVax 60 RIGScan CR 60 PhG alpha 1 60 Evoltra TM 60 brivanib 60 Bassil Dahiyat Ph.D. 60 ONCASPAR 60 CHOP chemotherapy 60 chemoprotective 60 GRNCM1 60 MGN# 60 tolevamer 60 Dr. Bruno Giannetti 60 vinca alkaloid 60 CytoFabTM 60 Lung transplantation 60 James Sapirstein 60 Amrubicin 60 ENMD # 60 myeloproliferative disorders 60 Neupogen ® 60 farletuzumab 60 oral Janus kinase 60 TKM PLK1 60 EGFR HER 60 antiangiogenesis 60 ThGRF 60 cytokine refractory 60 Actimmune ® 60 Cotara ® 60 vaccines oncolytic virus 60 bardoxolone methyl 60 Clolar ® 60 ATL# [001] 60 dose intramuscular 60 Advexin 60 HuMax TAC 60 INCB# [001] 60 docetaxel Taxotere 60 rheumatoid arthritis psoriatic arthritis 60 Virulizin R 60 recurrent metastatic 60 aerosolized AAT 60 small molecule tyrosine 60 Drew Fromkin President 60 cetuximab Erbitux 60 midstage trials 60 adrenergic regulation 60 RhuDex ® 60 molecular chaperone regulation 60 Glenn A. Oclassen 60 neuro protective 60 potent antiproliferative 60 Temsirolimus 60 taxane chemotherapy 59 KRAS mutated 59 Neogenix 59 Tectin TM 59 PRECISE Trial 59 oral clodronate 59 Apo2L 59 Chronic pancreatitis 59 AGILECT R 59 ZADAXIN ® 59 receptor inhibitor 59 Michel Morre DVM 59 Kirsten Drejer 59 Genz # 59 tezampanel NGX# 59 ORENCIA R 59 NicOx commented 59 refractory angina 59 recurrent glioblastoma multiforme 59 Hervé Hoppenot President 59 Richard Pazdur 59 Zybrestat 59 BRAF V# mutation 59 Ralph Makar 59 motexafin gadolinium 59 ARIKACE ™ 59 cisplatin resistant 59 gemifloxacin 59 G#DT 59 adecatumumab MT# 59 Lupus nephritis 59 mTOR inhibitors 59 MTP inhibitor 59 Targretin capsules 59 Elocalcitol 59 Pradefovir 59 Fludara ® 59 pamidronate 59 Tyrima 59 hematological malignancy 59 PF # [002] 59 multicenter Phase II 59 chronic ITP patients 59 6R BH4 59 Sulonex TM 59 thalassemia sickle cell 59 generation purine nucleoside 59 taxane chemotherapy administered 59 Nanobody 59 sulfonylurea glimepiride 59 cardio renal 59 curative therapy 59 inflammatory autoimmune diseases 59 hoFH 59 hormonally sensitive 59 acadesine 59 Lilly Alimta 59 CCR5 mAb 59 potent cytotoxic 59 ACV1 59 reduce serum phosphate 59 Armando Anido 59 antiangiogenic therapy 59 Neuradiab 59 eprodisate Fibrillex TM 59 YONDELIS R 59 Robert L. Bratzler 59 VEGF inhibitors 59 PNH patients 59 ALN HTT 59 XmAb# 59 ® lenalidomide 59 Ocrelizumab 59 adenosine A2A 59 TASKi3 59 OvaRex ® MAb 59 PD LID 59 synthetic retinoid 59 OXIGON TM 59 Nuvion 59 efaproxiral 59 Inc. Nasdaq NLTX 59 Fodosine 59 VitiGam 59 GW# [003] 59 Fablyn 59 Chronic myeloid leukemia 59 BNC# 59 FOLOTYN ® 59 Panzem NCD 59 mutated KRAS gene 59 bortezomib Velcade 59 carcinoma mCRC 59 CINTREDEKIN BESUDOTOX 59 pegfilgrastim 59 hypervascular tumors 59 antiangiogenic agents 59 Daniel Von Hoff 59 Garo H. 59 baminercept 59 Begins Dosing 59 serum uric acid sUA 59 Dr. Tashkin 59 Ixabepilone 59 squamous non 59 KNS # 59 vincristine sulfate 59 systemic antifungal 59 Dr. Michelle Berrey 59 potent triglyceride lowering 59 NTDDS 59 OncoVEX GM CSF 59 Amigal 59 systemic anaplastic large 59 receptor inhibiting monoclonal 59 therapeutic monoclonal antibodies 59 visilizumab 59 erlotinib Tarceva ® 59 hyperphenylalaninemia HPA due 59 immune modulator 59 developing Surfactant Therapies 59 HuMax EGFr 59 cancer immunotherapies 59 epithelial origin 59 ® bevacizumab 59 dimebon latrepirdine 59 rituximab Rituxan 59 compound INCB# 59 torezolid phosphate 59 SinuNase ™ 59 receiving chemoradiation therapy 59 MEK inhibitors 59 MKC# MT 59 humanised monoclonal antibody 59 Pyridorin 59 Zavesca r 59 Bystolic nebivolol 59 novel histone deacetylase 59 JAK#/JAK# inhibitor CYT# 59 malignant ascites 59 IMC A# 59 R lenalidomide 59 intranasal delivery 59 pharmacogenomic translational research 59 Cloretazine R VNP#M 59 mouse xenograft models 59 OMNARIS HFA 59 HuMax CD4 59 inhibit angiogenesis 59 triglyceride lowering 59 cilengitide 59 uric acid lowering 59 DPX Survivac 59 IRX 2 59 phase IIb trial 59 castration resistant hormone refractory 59 Panzem ® 59 hematological diseases 59 hematological toxicity 59 squamous cell lung cancer 59 ONTAK 59 HRPC 59 heavily pretreated 59 Bioaccelerate compounds under 59 brentuximab vedotin SGN 59 cisplatin carboplatin 59 Robert Motzer MD 59 Dr. Ayalew Tefferi 59 orally administered inhibitor 59 Lupuzor 59 GLPG# 59 Glioblastoma multiforme GBM 59 Thiovir 59 hematologic disorders 59 XL# XL# XL# XL# 59 cancer neuroendocrine tumor 59 cisplatin gemcitabine 59 investigational humanized monoclonal antibody 59 Gamunex C 59 overt nephropathy 59 Octreolin 59 metastatic sarcomas 59 Dr. Ivashkiv 59 John Maraganore Ph.D. 59 Surgical resection 59 antitumor effect 59 ThermoDox R 59 vorinostat 59 tumor metastases 59 milatuzumab 59 somatostatin analogues 59 Romidepsin 59 immunosuppressant therapies 59 Cloretazine ® 59 immunosuppressive regimens 59 anticancer activity 59 Aplidin R 59 inhibiting telomerase 59 Intravenous CP 59 pentostatin 59 Interferon beta 59 OXi# 59 microtubule inhibitor 59 Lisofylline 59 Perceiva 59 HCV antiviral 59 antiangiogenic 59 Gord Froehlich President 59 Alvesco R 59 ACAPODENE TM 59 PEGPH# 59 Aurora kinase inhibitor 59 anti EGFR antibody 59 Prodarsan R 59 oral ridaforolimus 59 oral anticancer 59 perampanel 59 Bioral ® 59 intra abdominal infections 59 epilepsy Parkinson disease 59 Viramidine 59 opioid induced bowel dysfunction 59 haematologic 59 intravascular hemolysis 59 beta 1a 59 elacytarabine 59 antiangiogenic drugs 59 regorafenib 59 KRAS mutant 59 squalamine 59 EGFR expressing 59 antimetastatic 59 hepatorenal syndrome 59 relapsed ovarian cancer 59 oral PTH 59 acute mania 59 ACTEMRA TM 59 Akt activation 59 anti atherothrombotic 59 Pertuzumab 59 hereditary emphysema 59 injectable investigational 59 SYN# 59 Preclinical studies suggest 59 StemEx R 59 indibulin 59 recombinant biopharmaceutical 59 non mutated KRAS 59 papillary renal cell carcinoma 59 FluCide 59 eltrombopag 59 5 fluorouracil leucovorin 59 psoriasis Crohn disease 59 Jevtana 59 AIDS prophylaxis congestive 59 intravenous immunoglobulin IVIg 59 Vidaza ® 59 novel oral anticoagulant 59 antimitotic 59 Cinryze ™ 59 adjuvant colon cancer 59 rALLy 59 pharmacological chaperone 59 metastatic gastric 59 nucleoside analog 59 Smac mimetic